NCT00104468 2008-01-17Study of Troxatylâ„¢ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)SGX Pharmaceuticals, Inc.Phase 1/2 Terminated50 enrolled
NCT00104286 2006-11-03Study of Troxatylâ„¢ Administered by Continuous Infusion to Subjects With Solid TumorsSGX Pharmaceuticals, Inc.Phase 1/2 Terminated50 enrolled